OAC0203	Mpox vaccination among gay, bisexual, and other men who have sex with men in the United States, september-december 2022	Oral abstract session with live Q&A	Epidemiology of HIV
OAC0204	Risk of hepatitis C infection following bacterial sexually transmissible infections among gay and bisexual men in Australia 2016-2020	Oral abstract session with live Q&A	Epidemiology of HIV
OAC0205	Integration of PrEP services and assisted partner notification into an STI Clinic in Lilongwe, Malawi	Oral abstract session with live Q&A	HIV prevention research
OAC0302	Enhanced linkage to care following home-based HIV testing improves linkage, ART initiation and retention, and 12-month viral suppression—the Ekkubo study: a cluster randomized trial in Uganda	Oral abstract session with live Q&A	Cascades of HIV care and treatment
OAC0303	The effect of primary health care on AIDS: a cohort study of 3.4 million individuals in Brazil	Oral abstract session with live Q&A	HIV prevention research
OAC0304	Initiation of pre-exposure prophylaxis (PrEP) among key populations in PEPFAR-supported countries during 2019–2022	Oral abstract session with live Q&A	HIV prevention research
OAC0305	Increased HIV prevention coverage among Australian gay and bisexual men with regular partners: results of national behavioural surveillance, 2018-22	Oral abstract session with live Q&A	HIV prevention research
OAC0402	No association between in-utero PrEP exposure and bone mineral density at 36 months of age among mother-infant pairs in Kenya	Oral abstract session with live Q&A	HIV prevention research
OAC0403	Cofactors of HIV self-testing and PrEP acceptance among pregnant women at high risk of HIV in Kenya	Oral abstract session with live Q&A	HIV testing
OAC0404	Drug-drug interaction between emtricitabine/tenofovir alafenamide (FTC/TAF)-based PrEP and feminizing hormones in transgender women: peripheral blood mononuclear cells and urine analysis from the iFACT3 study	Oral abstract session with live Q&A	HIV prevention research